Evidence map›Paper›PMID 38674129›Full record

ArticleInternational journal of molecular sciences2024

Profile of Lipoprotein Subclasses in Chinese Primary Open-Angle Glaucoma Patients.

Changzhen Fu, Jianming Xu, Shao-Lang Chen, Chong-Bo Chen, Jia-Jian Liang, Zibo Liu, Chukai Huang, Zhenggen Wu, Tsz Kin Ng, Mingzhi Zhang and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Observational
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 2 countries.

Changzhen FuJoint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou 515041, China.ORCID 0000-0002-3320-6262
Jianming XuJoint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou 515041, China.ORCID 0000-0002-8231-7858
Shao-Lang ChenJoint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou 515041, China.
Chong-Bo ChenJoint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou 515041, China.ORCID 0000-0003-1421-4109
Jia-Jian LiangJoint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou 515041, China.
Zibo LiuJoint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou 515041, China.
Chukai HuangJoint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou 515041, China.
Zhenggen WuJoint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou 515041, China.
Tsz Kin NgJoint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou 515041, China.ORCID 0000-0001-7863-7229
Mingzhi ZhangJoint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou 515041, China.
Qingping LiuJoint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou 515041, China.
Chinese University of Hong Kong · HK

Funding

Guangdong Basic and Applied Basic Research Foundation 2022A1515011646Guangdong Medical Research Foundation B2023373National Natural Science Foundation of China 82171044Shantou Medical Health, Science and Technology Project Foundation 220507146490632Shantou Medical Health, Science and Technology Project Foundation 220516106492037Special Project in Key Fields of Colleges and Universities in Guangdong Province 2021ZDZX2031
6 · The paper itself

Abstract

To investigate the plasma lipoprotein subclasses in patients with primary open-angle glaucoma (POAG), a total of 20 Chinese POAG patients on intraocular pressure (IOP)-lowering treatment and 20 age-matched control subjects were recruited. Based on the levels of total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C), the study subjects were divided into elevated- and normal-level subgroups. The plasma lipoprotein, lipoprotein subclasses, and oxidized LDL (oxLDL) levels were quantitatively measured. The discrimination potential of the lipoproteins was evaluated using the area under the receiver operating characteristic curve (AUC), and their correlation with clinical parameters was also evaluated. Compared to the control subjects with elevated TC and/or LDL-C levels, the levels of TC, LDL-C, non-high-density lipoprotein cholesterol (non-HDL), LDL subclass LDL3 and small dense LDL (sdLDL), and oxLDL were significantly higher in POAG patients with elevated TC and/or LDL-C levels. No differences in any lipoproteins or the subclasses were found between the POAG patients and control subjects with normal TC and LDL-C levels. Moderate-to-good performance of TC, LDL-C, non-HDL, LDL3, sdLDL, and oxLDL was found in discriminating between the POAG patients and control subjects with elevated TC and/or LDL-C levels (AUC: 0.710-0.950). Significant negative correlations between LDL3 and sdLDL with retinal nerve fiber layer (RNFL) thickness in the superior quadrant and between LDL3 and average RNFL thickness were observed in POAG patients with elevated TC and/or LDL-C levels. This study revealed a significant elevation of plasma lipoproteins, especially the LDL subclasses, in POAG patients with elevated TC and/or LDL-C levels, providing insights on monitoring specific lipoproteins in POAG patients with elevated TC and/or LDL-C.

Indexed as

Glaucoma, Open-AngleAgedCase-Control StudiesChinaCholesterolCholesterol, LDLEast Asian PeopleFemaleHumansIntraocular PressureLipoproteinsLipoproteins, LDLMaleMiddle AgedCholesterolCholesterol, LDLLipoproteinsLipoproteins, LDLoxidized low density lipoproteinlipoprotein subclassesoxidized LDLPOAGsmall dense LDL

Identifiers

PMID38674129
PMCPMC11050298
OpenAlexW4395000440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.